Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility

Colorectal Cancer Clinical Trial

Official title:

Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02321488
• Other study ID #: PA14-0935
• Secondary ID: CE 1304-6855
• Status: Recruiting
• Phase: N/A
• First received: December 17, 2014
• Last updated: July 8, 2016
• Start date: December 2014

Study information

• Verified date: July 2016
• Source: M.D. Anderson Cancer Center
• Contact: George Chang, MD, MS
• Phone: 713-792-6940
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Objectives:

1. Determine the surveillance practice patterns following curative resection of colorectal cancer

2. Identify patient characteristics related to eligibility for treatment after the detection of a colorectal cancer recurrence

Description:

A survey related to surveillance practice patterns following curative resection of colorectal cancer patients will be administered to eligible providers for them to complete. The survey collects basic information related to a providers' role in in colorectal care in addition to their perspective on patient characteristics that may directly influence a patients' ability to receive treatment for a recurrent colorectal cancer.

The surveys may be self-administered and completed anonymously, either in a hard copy or electronic formats. They may also be administered by the research personnel in a group setting for paper or electronic surveying. The surveys may be sent to providers as in PDF form for respondents to print and complete, handed out in person, emailed as a qualtrics study or electronically administered at a regularly occurring conference for colorectal cancer physicians. In the case the survey is electronically administered in a group setting, audience response equipment will be used. Individual data will be collected using electronic response devices. No personally identifying information will be collected. Participants will not be identifiable using data collected in these group settings. If the form is handed out in person, it will be given out and collected using a blank envelope to eliminate any way of identifying the provider completing it.

If respondents print and complete paper forms they will be ask to return them with no identifying information. Participants will be asked to place the deidentified survey in a sealed envelope and return through mail or in a drop-box placed in a common location, all envelopes returned to the study staff in person will be collected together and opened in aggregate. Electronically administered questionnaires, using audience response or a qualtrics survey, will have no identifying information.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Subjects are physicians or other providers who work in the Gastrointestinal and Colorectal Centers at MD Anderson Cancer Center OR are a member or guest of the ALLIANCE for Clinical Trials for Oncology OR academic and community providers to patients with colorectal cancer

2. Subjects are trained to provide care to colorectal cancer patients

3. Subjects are at least 18 years of age and have adequate command of English language

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms

Intervention

Behavioral:
• Survey
Survey related to surveillance practice patterns following curative resection of colorectal cancer patients administered to eligible providers for them to complete.

Locations

Country	Name	City	State
United States	University of Texas MD Anderson Cancer Center	Houston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center	Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Surveillance Practice Patterns Following Curative Resection of Colorectal Cancer	Descriptive statistics utilized to summarize survey data.	1 day	No

External Links

•   University of Texas MD Anderson Cancer Center Website